PACIRA BIOSCIENCES, INC.

Serial Number 90598390
Registration 6908097
700

Registration Progress

Application Filed
Mar 23, 2021
Under Examination
Jan 25, 2022
Approved for Publication
Nov 30, 2021
Published for Opposition
Nov 30, 2021
Registered
Nov 22, 2022

Basic Information

Serial Number
90598390
Registration Number
6908097
Filing Date
March 23, 2021
Registration Date
November 22, 2022
Published for Opposition
November 30, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 22, 2022
Registration
Registered
Classes
042

Rights Holder

Pacira Pharmaceuticals, Inc.

03
Address
5 Sylvan Way
Parsippany, NJ 07054

Ownership History

Pacira Pharmaceuticals, Inc.

Original Applicant
03
Parsippany, NJ

Pacira Pharmaceuticals, Inc.

Owner at Publication
03
Parsippany, NJ

Pacira Pharmaceuticals, Inc.

Original Registrant
03
Parsippany, NJ

Legal Representation

Attorney
Vanessa A. Ignacio, Esq.

USPTO Deadlines

Next Renewal Deadline
1233 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-11-22)
Due Date
November 22, 2028
Grace Period Ends
May 22, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description
Apr 19, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 22, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 22, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 15, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 14, 2022 DOCK D ASSIGNED TO EXAMINER
Oct 14, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 29, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 29, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 16, 2022 EISU I TEAS STATEMENT OF USE RECEIVED
Sep 16, 2022 IUAF S USE AMENDMENT FILED
Jul 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 25, 2022 EXT1 S SOU EXTENSION 1 FILED
Jul 25, 2022 EX1G S SOU EXTENSION 1 GRANTED
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 26, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 25, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 30, 2021 PUBO A PUBLISHED FOR OPPOSITION
Nov 30, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 28, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Oct 28, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED
Oct 28, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Oct 28, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2021 DOCK D ASSIGNED TO EXAMINER
Oct 27, 2021 CNRT R NON-FINAL ACTION WRITTEN
Oct 27, 2021 GNRT F NON-FINAL ACTION E-MAILED
Oct 27, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2021 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Scientific research and development services; development and engineering services in the field of surgical, diagnostic and therapeutic products; product development; design of new products for others; Design of medical goods for others, namely, drug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticals, made to the order or specification of others, for treatment of a wide variety of diseases
First Use Anywhere: 20190400
First Use in Commerce: 20190400

Additional Information

Design Mark
The mark consists of the word "PACIRA" in with an arch design running from the first "A" to the second "A" and the literal element "BIOSCIENCES, INC". directly underneath appearing in smaller font.
Pseudo Mark
PACIRA BIOSCIENCES, INCORPORATED

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOSCIENCES, INC."